DL-BETA-HYDROXYNORVALINE(34042-00-7)
- Name: DL-BETA-HYDROXYNORVALINE
- Synonyms:DL-BETA-HYDROXYNORVALINE;DL-3-HYDROXYNORVALINE;2-AMINO-3-HYDROXYPENTANOIC ACID;3-HYDROXY-2-AMINOPENTANOIC ACID;ALPHA-AMINO-BETA-HYDROXYVALERIC ACID;3-Hydroxynorvaline;β-Hydroxynorvaline;DL-B-HYDROXYNORVALINE
- Molecular Formula:C5H11NO3
- Molecular Weight:133.15
- CAS Registry Number:34042-00-7
- EINECS:
- Melting Point:224-226oC
- Water Solubility:H2O: 0.1 g/mL, clear, colorless
Other Product
- 753439-35-9/2-Naphthalenecarboximidamide, 7-[(2R)-1-(ethylsulfonyl)-2,3-dihydro-5-[[1-(1-iminoethyl)-4-piperidinyl]oxy]-1H-indol-2-yl]-
- 63435-76-7/Benzenecarboximidamide, 4,4'-[(2-oxo-1,3-cycloheptanediylidene)dimethylidyne]bis-
- 549506-83-4/1H-Azepine-1-acetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]hexahydro-2-oxo-3-[[(phenylmethyl)sulfonyl]amino]-, (3S)-
- 549506-52-7/1-Piperazineacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]-4-[(4-chlorophenyl)sulfonyl]-2-oxo-
- 206352-85-4/1(2H)-Pyridineacetamide, N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]-2-oxo-3-[[(phenylmethyl)sulfonyl]amino]-
- 334953-11-6/Glycinamide, 3-[1-(aminoiminomethyl)-4-piperidinyl]-N-[(phenylmethyl)sulfonyl]-D-alanyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]- (9CI)
- 186304-04-1/N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-(2-thiazolylcarbonyl)butyl]glycinamide
- 186369-21-1/N2-[(Phenylmethyl)sulfonyl]-D-arginyl-N-[(1S)-4-[(aminoiminomethyl)amino]-1-formylbutyl]glycinamide
- 637328-69-9/Tanogitran
- 1004990-28-6/1L-6-HYDROXYMETHYL-CHIRO-INOSITOL 2-(R)-2-O-METHYL-3-O-OCTADECYLCARBONATE
- 845614-11-1/[4-(3-Fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-Methylsulfonyl-2-[((S)-2,2,2-trifluoro-1-methylethyl)oxy]phenyl]methanone
- 845609-54-3/4-[4-[2-(Cyclopropylmethoxy)-5-methylsulfonylbenzoyl]piperazin-1-yl]-3-fluorobenzonitrile
- 310415-30-6/1-[4-[4-[2-(Morpholin-4-yl)-5-nitrobenzoyl]piperazin-1-yl]-3-fluorophenyl]ethanone
- 851337-24-1/1-Phenyl-8-[(1S,2S)-2-phenylcyclohexyl]-1,3,8-triazaspiro[4.5]decan-4-one
- 1173177-11-1/N-[(3-Chloro-4-fluorophenyl)methyl]-1-methyl-N-[[(1alpha,5alpha,6alpha)-3-methyl-3-azabicyclo[3.1.0]hex-6-yl]methyl]-1H-imidazole-4-carboxamide hydrochloride
- 615571-23-8/2-Chloro-3-(trifluoromethyl)-N-((S)-phenyl((S)-piperidin-2-yl)methyl)benzamide hydrochloride
- 556113-62-3/(2R)-4-[5-Chloro-2-[(4-methoxyphenyl)thio]phenyl]-2-methyl-1-piperazineacetic acid
- 722456-08-8/Org 24598 lithium salt
- 372198-97-5/N-Methyl-N-[(3R)-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl]glycine
- 34042-00-7/DL-BETA-HYDROXYNORVALINE
- 1109-96-2/Silicic acid, ethyl ester
- 692764-89-9/5-(4-Methoxy[1,1'-biphenyl]-3-yl)-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 612530-44-6/5-Phenyl-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 945836-48-6/5-[3-[2-[[4'-(Cyclohexylmethoxy)[1,1'-biphenyl]-4-yl]methyl]-4-(2,4-dichlorophenyl)-1H-imidazol-1-yl]phenyl]-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 941607-78-9/5-[4-(Cyclohexylmethyl)-2-fluoro-6-hydroxyphenyl]-1,2,5-thiadiazolidin-3-one 1,1-dioxide
- 327033-16-9/4-Thiazolidinone, 3-(3-chlorophenyl)-5-[(4-hydroxy-3-methoxy-5-nitrophenyl)methylene]-2-thioxo-
- 446043-04-5/[1,1':4',1''-Terphenyl]-3-methanesulfonic acid, α,α-difluoro-, ammonium salt (9CI)
- 1000611-47-1/Pentanoic acid, 2-[[[(1S)-1-(4-ethyl-2-thiazolyl)-2-[4-(sulfoamino)phenyl]ethyl]amino]carbonyl]-4-methyl-, 1-methyl ester, (2S)-
- 875662-69-4/Sulfamic acid, N-[3-[3-[(3S)-3,4-dihydro-3-[(methylamino)carbonyl]-7-(sulfoamino)-2(1H)-isoquinolinyl]-3-oxopropyl]phenyl]-
- 329317-94-4/Methanesulfonamide, N,N'-[1,4-phenylenebis(oxy-4,1-phenylene)]bis[1,1,1-trifluoro- (9CI)